Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-05-24 00:00:00 ET · period of report 2022-05-20 · accession 0001209191-22-031619 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-05-24 | 2022-05-20 | PCVX | Fairman Jeff | VP, Research | S - Sale | $25.50 | -4,112 | 321.2K | -1% | -$104.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-20 | S | D | 4,112 | $25.50 | 321,227 | I By Fairman Family Trust | — | — |